We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Test for Early Osteoarthritis Diagnosis to Improve Clinical Decision-Making

By LabMedica International staff writers
Posted on 18 Dec 2024

As the population ages, the prevalence of osteoarthritis (OA) continues to rise. More...

Typically, osteoarthritis is diagnosed in its later stages when cartilage degradation is advanced, making it challenging to differentiate from other forms of arthritis. Accurate differentiation of primary osteoarthritis from other arthritic conditions is essential for effective treatment strategies. Now, researchers have developed a new diagnostic test utilizing a dual-biomarker algorithm to aid in the diagnosis of osteoarthritis.

Developed and tested by CD Diagnostics (Claymont, DE, USA), the new test analyzes two markers found in the synovial fluid of patients' joints. The test employs a dual-biomarker algorithm to inform osteoarthritis diagnosis. In patients with confirmed primary osteoarthritis in the study, synovial fluid showed elevated levels of cartilage oligomeric matrix protein. However, this biomarker alone was not sufficient to differentiate primary osteoarthritis from other inflammatory conditions that also result in cartilage damage. To address this, the team also assessed levels of cartilage oligomeric matrix protein and interleukin-8. Using the ratio of these two markers, they developed an algorithm that was validated in differentiating osteoarthritis from inflammatory arthritis in 171 knee synovial fluid specimens.

The results, published in the Journal of Orthopedic Research, showed that the osteoarthritis algorithm achieved clinical sensitivity and specificity of 87.0% and 88.9%, respectively. This is the first report of a biomarker test capable of distinguishing primary osteoarthritis from inflammatory arthritis with a high degree of accuracy. This innovative dual-biomarker algorithm, based on synovial fluid analysis, represents a significant advancement in the accurate diagnosis of osteoarthritis, particularly in distinguishing it from inflammatory arthritis. The approach holds great promise for improving clinical decision-making and patient outcomes, addressing a critical gap in arthritis diagnosis.

“This study addresses an unmet need for objective diagnosis of osteoarthritis to improve clinical decision-making and patient outcomes,” said corresponding author Daniel Keter, BA, of CD Diagnostics, A Division of Zimmer Biomet.

Related Links:
CD Diagnostics


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
8-Channel Pipette
SAPPHIRE 20–300 µL
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.